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DepressionMethods: Children (5–15 years) with active epilepsy were screened using the parent-report (n = 69) and self-
report (n = 48) versions of the Spence Children's Anxiety Scale (SCAS) and the self-report version of the
Children's Depression Inventory (CDI) (n = 48) in a population-based sample.
Results: A total of 32.2% of children (self-report) and 15.2% of children (parent-report) scored ≥1 SD above the
mean on the SCAS total score. The subscales wheremost difﬁculty were reported on parent-report were Physical
Injury and Separation Anxiety. There was less variation on self-report. On the CDI, 20.9% of young people scored
≥1 SD above the mean. Children reported signiﬁcantly more symptoms of anxiety on the SCAS total score and
three of the subscales (p b .05). There was a signiﬁcant effect on the SCAS total score of respondents by seizure
type interaction, suggesting higher scores on SCAS for children with generalized seizures on self- but not
parent-report. Higher CDI scores were signiﬁcantly associated with generalized seizures (p N .05).
Summary: Symptoms of anxietyweremore commonbased on self-report comparedwith parent-report. Children
with generalized seizures reported more symptoms of depression and anxiety.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
In addition to epileptic seizures, there is a high associationwith cog-
nitive, psychiatric, motor and academic achievement difﬁculties in
childhood epilepsy [1,2]. Children with epilepsy have higher rates of
neurodevelopmental and psychiatric difﬁculties compared with the
general pediatric population and children with other non-neurological
chronic conditions based on diagnostic interviews, parent report of di-
agnoses, and self-report checklists [3–5]. The strongest predictors of de-
creased quality of life in childhood epilepsy are often psychiatric
difﬁculties [6,7], particularly depression and anxiety [8,9]. Therefore,
identiﬁcation of the extent and nature of symptoms of depression and
anxiety would seem crucial with respect to promoting quality of life
in childhood epilepsy. However, neurodevelopmental and psychiatric
difﬁculties are often not identiﬁed or treated [1,10].
Population-based studies indicate that both depression and anxiety
are more common in childhood epilepsy than in the general pediatricgEpilepsy, Lingﬁeld, SurreyRH7
y).population [3,4] and in children with diabetes [4]. There is a lack of
population-based data on proﬁles of symptoms of anxiety [11] and de-
pression in childhood epilepsy. Knowledge of proﬁles (i.e., what types of
symptoms of anxiety and depression)may be important not onlywith re-
spect to treatment but also with respect to understanding possible con-
tributors to the symptoms. With respect to the role of epilepsy/seizure
variables in symptoms of depression and anxiety, ﬁndings have been
mixed. Seizure type has not been associated with symptoms of anxiety
and depression in most studies [12], but an increased risk has been
noted in two studies [13,14].With regard to seizure frequency or severity,
an increased risk of symptoms of anxiety and/or depression has been
noted in some [15,16], but not all, studies [17]. It has been suggested
that in most studies of adolescents with epilepsy, antiepileptic drug
(AED) use and type of AED have not been found to be consistent predic-
tors of depression [18]. However, polytherapy (being on more than one
AED) has been associated with increased symptoms of depression
[19–21] and anxiety [7,21]. Furthermore, there is a paucity of evidence
of the impact of speciﬁc AEDs on emotional symptoms. Increased dura-
tion of epilepsy has not been associated with symptoms of anxiety or de-
pression [20,22]. With regard to informants, it is important that where
possible, children and adolescents are asked about symptoms of
85 children underwent 
psychological assessment 
Parents of 69 children 
completed the SCAS-PR
48 children completed CDI 
and SCAS-SR
Parents of 16 children with an IQ 
score <35 did not complete 
SCAS-PR
21 children were unable to 
complete SCAS-SR or CDI due 
to age or level of cognitive 
functioning. 
Fig. 1. Assessment of anxiety and depression in the CHESS study. SCAS-PR= Spence Chil-
drenAnxiety Scale— Parent-Report, SCAS-SR Spence ChildrenAnxiety Scale— Self-Report,
CDI — Children's Depression Inventory.
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of the conditions, informants such as parents and teachers may not be
aware of depressive and anxiety symptoms the children are experiencing
[14,23].
In summary, there is a lack of population-based data on proﬁles of
symptoms of anxiety and depression in childhood epilepsy and the
role of epilepsy/seizure variables. Population-based studies are impor-
tant in epilepsy since studies from specialized centers are likely to be bi-
ased in terms of severity and not representative. Many of the previous
studies of depression and anxiety in children with epilepsy have fo-
cussed on children with refractory epilepsy and/or children attending
tertiary epilepsy centers. The Children with Epilepsy in Sussex School
(CHESS) study is a population-based study focussed on the learning
and behavioral difﬁculties of school-aged children with active epilepsy
(on AEDs and/or had a seizure in the last year). We have previously de-
scribed this group with respect to DSM-IV-TR diagnoses [1]. We report-
ed that 13% (n = 11) met DSM-IV-TR criteria for any anxiety disorder,
and 7% (n = 6) met DSM-IV-TR criteria for depression. Only one child
who met criteria for an anxiety disorder and one who met criteria for
depression had previously been diagnosed. On univariable and multi-
variable analyses, none of the epilepsy factors were signiﬁcantly associ-
ated with diagnoses of depression or anxiety. The aim of the current
study was to report on the proﬁle of symptoms on self-reported and
parent-reported measures of anxiety and on a self-reported measure
of depression. A further aimwas to compare child and parent responses
on a measure of anxiety. The ﬁnal aims were to assess the contribution
of seizure-related variables to symptoms of anxiety and see if they dif-
fered between respondents and to assess the role of seizure-related var-
iables on self-reported symptoms of depression.
2. Materials and methods
The CHESS study involved the identiﬁcation of children with epilep-
sy born between 1995 and 2007 and resident in the RH10 to RH13 post-
al districts in the south of England between March 31st 2011 and
September 30th 2012 (for a detailed description of ascertainment, see
Reilly et al. 2014 [9]). The children were identiﬁed via a computerized
database and liaison with local pediatricians. The prevalence of lifetime
(ahistory of 2 ormore unprovoked epileptic seizures) and active epilep-
sy in the study area was calculated by using the mid-2010 population
estimates of 4- to 15-year-olds (32,212) and 5- to 16-year-olds
(32,617) provided by the Ofﬁce of National Statistics (total mid-2010
population 202,919). The prevalence of lifetime epilepsy was 6.1 (95%
conﬁdence interval [CI]: 5.2–6.9) per 1000 (1 in 175), and the preva-
lence of active epilepsy was 3.5 (95% CI: 3.0–4.3) per 1000 (1 in 286).
The parents/guardians of children with active epilepsy were
approached by the researchers (sent a letter and/or asked in person)
and asked to complete an interest form if they wished to ﬁnd out
about the study. All parentswho returned a formweremet in the child's
school or home by the study psychologist to discuss their child's partic-
ipation. At this informed consent meeting, the study was described in
detail, and parents were asked for written consent for entry of their
child into the study. Children, where developmentally appropriate
(children 7 years or older who did not have intellectual disability),
were also asked to provide assent. Parents and children (where devel-
opmentally appropriate) were given information sheets describing the
purpose of the study. Parents or participants did not receive payment
for participating. Of those who were eligible, 85 (74%) parents
consented for their child to participate in the study. The 85 children
underwent comprehensive psychological assessment between April
1st 2011 and November 30th 2012. All 85 children completed the
study. Assessment included measures of cognition, behavior, emotional
functioning, and motor functioning (see Reilly et al. 2014 [9]). Levels of
global cognitive functioning and subsequent classiﬁcation of intellectual
disability (IQ b 70)were determined by full-scale IQ scores on standard-
ized tests of cognitive functioning.Diagnostic and StatisticalManual ofMental Disorders— Text Revision
diagnoses of depressive and anxiety disorders were made based on con-
sensus diagnosis by study psychologist, pediatrician, and child and ado-
lescent psychiatrist. The consensus diagnostic process involved a review
of each child's developmental/medical history based on case/medical
notes, results of administered standardized screening measures and cog-
nitive assessments, parent and teacher reports, and school-based obser-
vations by the study psychologist. All children regardless of intellectual
disability were considered for a diagnosis of depression and anxiety. In
relation to depression in children with intellectual disability, parents
were asked about symptoms of depression based on DSM-IV-TR criteria.
Clinical information on eligible children was extracted using a standard-
ized pro forma. Data obtained from the standardized pro forma included
current AEDs, duration of epilepsy, and investigations (MRI andEEG). Sei-
zure frequency was based on parent reports and was categorized as
weekly/more often or less frequent/none.
The ﬁnal sample for the current study contained 69 children
(see Fig. 1). In relation to anxiety and depression, parents of the children
(5–15 years) who had an IQ N 34 (n= 69) completed the parent version
of the Spence Anxiety Scale for Children (SCAS) [24]. The SCAS was not
completed by parents of children with an IQ b34 (n = 16) as it was not
thought to be valid with children functioning in the severe-profound
range of ID based on parent feedback. Parents reported that some items
were not suitable for children in this range of cognitive functioning, as
the items referred to children who were verbal and/or had a higher
level of ability compared with the child they were asked to respond
about. Childrenwith an IQN69andwhowere 7years of age or older com-
pleted the self-report versionof the SCAS (n=48) [25] and the Children's
Depression Inventory (CDI) (n = 48) [26]. A psychologist was present
with the children when they completed the instruments to provide clar-
iﬁcation if needed. Childrenwith an IQ between 50 and 69were asked to
complete the self-report version of the SCAS and CDI. However, the chil-
dren had difﬁculty completing these instruments. The psychologist who
was with the children when they completed the instruments did not
feel that the children sufﬁciently understood the questions for them to
be a valid measure of the children's emotional symptoms. This view
was formed based on the questions asked by the children about the
items and the number of uncompleted items which indicated a lack of
understanding. As a result, the responses of children with an IQ score be-
tween 50 and 69 were excluded from analysis. An example of an item
that was not deemed suitable for children with ID, based on their per-
ceived lack of understanding,was ‘I can't seem to get bad or silly thoughts
out of my head’.
The Spence Children's Anxiety Scale is one of the most widely used
questionnaires to assess perceptions of the frequency with which a
Table 1
Demographics of the children in the CHESS study who underwent assessment of symp-
toms of anxiety and depression (n = 69)a.
Sample (n = 69)
Sex: male/female 36/33 (52%/48%)
Ethnicity: white/nonwhite 55/14 (80%/20%)
Primary school/secondary school 39 (57%)/30 (43%)
Duration of epilepsy
b4 years 29 (42%)
≥4 years 40 (58%)
Mean age at the time of psychological assessment 10.70 years (5.08–15.75)
Under 11 years of age 37 (54%)
11 years or older 32 (46%)
Seizure frequencyb
Weekly or more often 22 (32%)
Less frequent or none 47 (68%)
Monotherapy/polytherapy/none 46 (66%)/19 (28%)/4 (6%)
Types of AEDs
Sodium valproate 26 (38%)
Lamotrigine 17 (25%)
Levetiracetam 10 (14%)
Topiramate 8 (12%)
Ethosuximide 7 (10%)
Clobazam 6 (9%)
Carbamazepine 4 (6%)
Ruﬁnamide 2 (3%)
Oxcarbazepine 2 (3%)
Zonisamide 2 (3%)
Clonazepam 1 (1%)
Stiripentol 1 (1%)
ILAE 2010 predominant seizure type: generalized/focalc 21 (30%)/48 (70%)
ILAE = International League Against Epilepsy.
a All data based on a review of medical notes unless otherwise indicated.
b Data based on parental reports.
c Based on consensus classiﬁcation by two pediatric neurologists.
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disorder, separation anxiety, social phobia, panic disorder and agora-
phobia, obsessive–compulsive disorder, and fears of physical injury. It
has good reliability, internal consistency, and validity [27]. The accom-
panying parent version (SCAS-P [24]) allows for comparisons between
child and parent ratings of the same symptoms. Both versions of the
SCAS are based on a four-point Likert-type response scale: ‘never’,
‘sometimes’, ‘often’, and ‘always’. The parent version contains 38
items, and the child version contains the same 38 items plus six ﬁller
items, which are not included in the ﬁnal scoring. Norms are available
for children 8–15 years of age, but norms are not available for children
7 years of age and younger. In this study, we used the norms for 8-
year-olds for children 7 years of age and younger as agreed with SCAS
authors (Hearn, 2013, personal correspondence).
The CDI [26] is a commonly used self-report measure of depressive
symptoms for children 7–17 years of age. The scale comprises 27 items
dealingwith sadness, self-blame, insomnia, loss of appetite, interpersonal
relationships, and school adjustment. Children's Depression Inventory
items are rated on a three-point scale (0 = not true, 1 = somewhat
true, 2 = very true), reﬂecting the degree of symptoms of depression
over the past 2 weeks. A total CDI score can be calculated by adding the
responses of all items. Internal consistency, moderate retest reliability,
and convergent validity of the CDI have been demonstrated [28,29].
2.1. Statistical analysis
All analyses were done with IBM SPSS version 21.0 (Armonk, NY,
USA). Descriptive statistics were used to indicate the distribution of
symptoms on the SCAS and CDI. On the CDI and SCAS, scores were cate-
gorized into 1 SD, 1–2 SD, and 2 SD above themean based on comparison
with published norms (http://www.scaswebsite.com and Kovacs [26]).
Paired-sample two-tailed t-tests were used to compare parent-report
and self-report total SCAS scores. Results for the paired samples t-tests
are reported before and after Bonferroni correction (adjusted alpha
p b .007 for t-tests). Reliability analysis for the SCAS and CDI is based on
Cronbach's alpha.
Multiple regression applying generalized estimating equation
modeling was used to identify epilepsy-related factors associated with
child and parent responses on the SCAS total score. The predictors in
the model were respondent (child vs. parent), seizure frequency
(weekly/more often vs. less frequent/none), predominant seizure type
(generalized vs. focal), duration (less than 4 years vs. greater than 4
years), AEDs (monotherapy vs. polytherapy), gender (male vs. female),
and age (b11 or ≥11 years). In the ﬁrst instance, all predictors and all
possible respondent × seizure factor interactions were tested ﬁrst to
see if any were signiﬁcant at the .05 level. Factors and interactions sig-
niﬁcant at the p b 0.05 level in initial modeling were subsequently in-
cluded in model 1, and model 2 shows the regression estimates of the
predictors of SCAS scores that were signiﬁcant at the .05 level in
model 1.
Univariable linear regression analyses were done to identify factors
associated with the CDI total score. The factors in the model were the
same as in the model for the SCAS (i.e., gender, age, seizure frequency,
AEDs, duration, and predominant seizure type) with the exception of
respondent.Multivariable analysis was carried out via backward regres-
sion with all predictors entered into the model to identify factors inde-
pendently associated with the outcome variable. Residual analyses
revealed that assumptions for the linear regression model were met.
The alpha level for univariable and multivariable analyses was p b 0.05.
2.2. Ethics
The study was approved by the Brighton and Sussex Research Ethics
Committee and was also registered with the collaborating hospital pri-
mary care organization — The Sussex Community NHS Trust. Informed
consent was obtained from parents of all participating children.3. Results
3.1. Child characteristics
Table 1 shows the characteristics of the childrenwho underwent as-
sessment of symptoms of anxiety and depression.
3.2. Scores on the Spence Children's Anxiety Scale (SCAS)
Cronbach's alpha values for the SCAS were 0.898 (child report) and
0.907 (parent report). Table 2 shows the categorizations on the SCAS
for the total score and the subscale scores (parent-/caregiver-report
(n = 69) and self-report (n = 48)) based on normal, between 1–2 SD
and 2 SD above the mean.
On the total score, 31% of self-report and 15% of parent scoreswere 1
SD (84th percentile) or more above the mean. On self-report, the sub-
scales where most children were above 1 SD cutoff were Panic (39.6%)
and Physical Injury (39.6%). Social Phobia was the subscale where the
least children were ≥1 SD above the mean. On parent report, Physical
Injury (37.9%) and Separation Anxiety (31.8%) were the subscales
with most children ≥1 SD above the mean, whereas the OCD subscale
(9.1%) was the area where the fewest children were in the at-risk cate-
gory. The two items with the highest mean scores on the parent mea-
sure were ‘my child worries’ and ‘my child is scared’. On the self-
report measure, the two items with the highest mean scores were
‘When I have a problem, my heart beats really fast’ and ‘I have to keep
checking that I have done things correct’.
Paired sample t-tests were conducted to compare self-report and
parent-report responses on SCAS where both parent and child re-
sponses were available for the same child (n = 48). The mean scores,
standard deviations, p-values, and effect sizes are shown in Supplemen-
tal Table 1 (Supplementary material A). Self-report scores were signiﬁ-
cantly higher (at least p b .05) based on paired samples t-test for the
Table 2
Self-report (n = 48) and parent categorizations (n = 69) on SCAS in the CHESS study.
Subscale Normal
(1st to 83rd
percentile)
1–2 SD
(84th to 97.4th
percentile)
N2 SD
(97.5th percentile
to 99th percentile)
Self-report Parent Self-report Parent Self-report Parent
Total 68.8% 84.8% 22.9% 12.1% 8.3% 3%
OCD 66.7% 90.9% 27.1% 6.1% 6.3% 3%
Social Phobia 70.8% 83.3% 25% 10.6% 4.2% 6.1%
Panic 60.4% 81.8% 31.3% 16.7% 8.3% 1.5%
Separation
Anxiety
64.6% 68.2% 20.8% 25.8% 14.6% 6.1%
Physical Injury 60.4% 62.1% 33.3% 28.8% 6.3% 9.1%
Generalized
Anxiety
64.6% 87.9% 20.8% 10.6% 14.6% 1.5%
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Bonferroni correction (adjusted p b .007), differences between parent-
report and self-report scores remained signiﬁcant for the total score
and the OCD and Panic subscales.
3.3. Scores on Child Depression Inventory (CDI)
Cronbach's alpha for the CDIwas 0.896 (child report). Table 3 shows
the responses of participants (n = 48) on the CDI.
Twenty-one percent of the children scored in the at-risk category
(1 SD or more above the 50th percentile). Ineffectiveness and Anhedo-
nia were the two subscales where most children scored above the 1 SD
cutoff, while Interpersonal Problems was the subscale where the least
number scored above the cutoff. The items most often endorsed were
‘making upmymind’ and ‘schoolwork effort’. In relation to suicidal ide-
ation, seven children responded that it was ‘somewhat true’ with re-
spect to the statement that they thought about killing themselves and
2 responded that it was ‘very true’.
3.4. Regression analyses
The full results of the generalized estimating equations for the SCAS
total score are in Table 4.
The interactions involving respondents which were found to be
signiﬁcant at the p b .05 level were respondent × seizure type,
respondent × duration, and respondent × gender, and these were in-
cluded in model 1, along with respondent and age category which
were also found to be signiﬁcant on univariable analysis. The other ep-
ilepsy-related factors were not found to be signiﬁcant predictors of
SCAS total scores. Respondent × gender interaction was signiﬁcant in
univariable analysis butwas not signiﬁcant inmodel 1 and, thus, not in-
cluded in model 2.
In the ﬁnal model, the factors signiﬁcantly associated with SCAS
scores were respondent (children reported more symptoms compared
with parents), age (older children reported more symptoms compared
with younger children), respondent × duration interaction, and
respondent × seizure interaction. The signiﬁcant respondent × seizure
type interaction suggests that the difference between generalized andTable 3
Scores on subscales of the CDI in the CHESS study (n = 48).
Subscales Mean score Normal T-score 60–70 T-score 70+
1–2 SD N2 SD
Negative Mood 2.67 79.2% 12.5% 8.3%
Interpersonal Problems 0.97 85.4% 12.6% 2.1%
Ineffectiveness 2.37 72.9% 18.7% 8.3%
Anhedonia 4.19 72.9% 22.9% 4.2%
Negative Self-esteem 2.21 83% 6.4% 10.6%
Total 12.40 79.1% 10.5% 10.4%focal seizures ismuch greater based on child report than on parent report
(see graph in Supplementary material B). The signiﬁcant respondent x
duration interaction suggests that the difference between short duration
and long duration is much greater based on parent report than on child
report (see graph in Supplementary material C).
Table 5 shows the factors signiﬁcantly associated with the CDI total
score on univariable and multivariable analyses.
Seizure type was the only factor signiﬁcantly associated (p b 0.05)
with the total score on the CDI on univariable and multivariable analy-
ses, with generalized seizures being associated with higher scores on
the CDI.
4. Discussion
The CHESS study is the ﬁrst population-based study to report on pro-
ﬁles of symptoms of anxiety and depression on standardized instruments
in childhood epilepsy. Previous population-based studies of childrenwith
epilepsy have not described proﬁles in detail and/or have focused on chil-
dren who meet diagnostic criteria for depression and anxiety. Under-
standing the proﬁle of symptoms of anxiety and depression may be
important with respect to treatment and also possible contributory fac-
tors. Symptom checklists can provide information on subclinical symp-
toms and allow identiﬁcation of children who are risk of signiﬁcant
impairment who with support may not develop a clinically signiﬁcant
disorder. Compared with published norms, which come from a large
community sample of Australian children (http://www.scaswebsite.
com), the current study suggests that children with epilepsy experience
more symptoms of anxiety than would be expected based on self-
report but not on parent-report. Symptoms of depression experienced
by the children would not appear to be as common as symptoms of anx-
iety but are slightly above published norms, which come from a commu-
nity-based sample of school children in the US [26].
With respect to subscales on a measure of anxiety, variation be-
tween subscales in the proportion of children scoring in the abnormal
range was more marked on the parent-report scale compared with
the self-report scale. On parent-report, 30+% of children scored in the
abnormal range on the Physical Injury and Separation Anxiety sub-
scales, whereas only 9% of children were in the abnormal range on the
OCD subscale. A possible explanation is that parents are more aware
of anxieties around physical injury and separation anxiety but less
aware of obsessions and compulsions. Elevated symptoms of separation
anxiety in childhood epilepsy may result from both parents and chil-
dren fearing the child being alone in the event of an epileptic seizure.
Furthermore, parents and childrenmay fear that if they are not together,
other adults may not know how tomanage a seizure. In relation to anx-
iety about physical injury, parents and children may fear that a seizure
could result in physical injury and, as a result, are more anxious about
this than would be the case for children without epilepsy. A previous
study of parent-reported symptoms of anxiety in childrenwith epilepsy
noted that the areas where most children scored above at-risk cutoffs
were speciﬁc phobia, obsessions, and post-traumatic stress disorder
[17].Much fewer children scored in the at-risk range of generalized anx-
iety disorder, separation anxiety, and social phobia [17]. Jones et al. [30]
reported the prevalence rates of several subtypes of DSM-IV anxiety dis-
orders including OCD (11%), speciﬁc phobia (8%), social phobia (8%),
overanxious disorder (6%), separation disorder (2%), and PTSD (2%).
Differences between the current study and previous studies likely re-
ﬂect the instruments/diagnostic methods used and the populations
sampled. These previous studies, although largerwith respect to sample
size than the current study, were not population-based and, thus, may
not be as representative.
Previous population-based researchhas identiﬁed that childrenwith
epilepsy are at high risk of symptoms of anxiety, but the ﬁndings of the
current study show that parents and children can differ signiﬁcantly
with respect to reporting of symptoms. This is important to note,
given that it has been recommended that children with epilepsy be
Table 4
Results of generalized estimating equations for the SCAS total score.
Predictor Model 1 Model 2
B (95% CI) p B (95% CI) p
Respondent 28.34 (16.51 to 40.168) .000 18.87 (9.81–27.93) .000
Age category −9.57 (−18.08 to−1.43) .022 −10.31 (−19.22 to−1.41) .023
Respondent by seizure type −17.77 (−30.87 to−4.48) .008 −17.93 (−31.18 to−4.678) .008
Respondent by duration 15.19 (5.41 to 24.98) .002 14.852 (4.65 to 25.05) .004
Respondent by gender 6.353 (−2.32 to 15.02) .151 n/a n/a
n/a as not in ﬁnal model.
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on parent-report or self-report will result in a different set of children
being identiﬁed as at-risk. It would appear particularly important that
views of children are accessed, given the internalizing nature of symp-
toms of depression and anxiety as parents may not be aware of the
symptoms the children are experiencing. However, children with
intellectual disability are not likely to be able to complete the currently
available standardized instruments. There is, thus, a need to develop
measures which can allow at least some children with intellectual
disability to indicate their views regarding these symptoms, as well as
asking parents and other family members about the child's emotional
well-being. In the absence of appropriate instruments, clinicians may
need to adapt their language for younger children and children with
cognitive impairment in order to access reports about symptoms of
emotional disorders. In general, it is important that clinicians working
with children with epilepsy also ask the child about symptoms of de-
pression and anxiety, as well as using standardized instruments, as
thiswill helpwith respect to clarifyingwhether the children understand
questions on standardized instruments.
In the current study, age category was signiﬁcantly associated with
scores on the SCAS, with older children beingmore at risk of symptoms
of anxiety than young children as has been noted in previous studies
[21,32]. This may reﬂect a greater awareness of the psychosocial impact
of epilepsy with age and other psychosocial and biological factors. The
nature of the association between duration and SCAS scores indicates
that while parent ratings of their child's anxiety decreases over time,
the child's ratings remain more stable. This might reﬂect increased pa-
rental stress and anxiety at the time of diagnosis or better coping, but
measures of parental anxiety and coping would be needed to verify
this. In relation to the signiﬁcant respondent x seizure type relationship,
generalized seizures contributed more to increased levels of anxiety
compared with focal seizures but only on self-report. It is possible that
generalized seizures, which are likely to be more visible and involve a
loss of consciousness, may impact very signiﬁcantly on the child's
level of anxiety but less so on parents' perceptions of their child's anxi-
ety. The signiﬁcant impact of seizure type on depression scoresmay also
reﬂect an increased awareness among children of these types of
seizures. Furthermore, we have previously reported that generalized
seizures are associated with deﬁcits in working memory in this sample
[33], which may contribute to difﬁculties in school and everyday life
resulting in increased symptoms of depression and anxiety. OtherTable 5
Factors associated with the CDI total score on univariable linear regression and on multivariab
Predictor Univarable
B (95% CI)
Gender 3.97 (−1.19 to 9.13)
Age category 7.259 (−1.86 to 8.53)
AED usage 1.41 (−4.98 to 7.79)
Seizure frequency −1.67 (−7.58 to 4.24)
Seizure type −10.219 (−15.71 to−4.73)
Seizure duration 0.972 (−5.11 to 7.052)
n/a as not in ﬁnal model.factors such as seizure frequency, AED usage, and gender were not sig-
niﬁcantly associatedwith scores onmeasures of depression and anxiety
unlike some previous studies. This may reﬂect the fact that the current
study was population-based and the measures we employed.
There is accumulating evidence that symptoms of both depression
[34,35] and anxiety [36] can be successfully treated in children with ep-
ilepsy although larger-scale studies are needed. A pilot study suggests
that cognitive behavioral therapy (CBT) may be useful in treating chil-
dren with epilepsy and social anxiety [37], and there is a need for
more studies focusing on speciﬁc types of depression and anxiety in
childhood epilepsy. Psychoeducation programs for children with epi-
lepsy and their parents should highlight the risks of both depression
and anxiety in childhood epilepsy. Such programs should also indicate
to children and parents that there is an expanding evidence base for
CBT in childhood epilepsy. Childhood epilepsy services will beneﬁt
from the development of clear pathways for children with epilepsy
who screen positive for depression and/or anxiety disorder, including
the provision of CBT where appropriate. It has been suggested that all
children with epilepsy be screened for symptoms of behavioral and
emotional disorders [1]. Instruments focusing on a broad range of be-
havioral and emotional difﬁculties may be useful at initial screening to
indicate problematic functioning [38], whereas instruments such as
the SCAS may be useful as a second stage screener, to identify disorder
speciﬁc symptoms.4.1. Limitations
A number of limitations need to be noted in interpreting the study
ﬁndings. The sample size is relatively small, and there is a need for fur-
ther studies with larger sample sizes. We used the parent version of the
SCAS with children 7 years of age and younger, despite the absence of
published norms, and thismay have impacted on the proportion of chil-
dren identiﬁed as at-risk. We did not use the parent report version of
the CDI to measure depression which would have been informative.
We considered a relatively limited range of possible contributory factors
to symptoms of depression and anxiety, and other factors such as paren-
tal well-being and other behavioral/psychiatric disorders would have
been informative. We were not able to assess the contribution of indi-
vidual AEDs to symptoms of depression and anxiety because of the
small sample size, and seizure frequency was based on parent reports.le linear regression.
Multivariable
p B (95% CI) p
.128 3.91 (−0.54 to 8.36) .083
.203 4.252 (−0.37 to 8.87) .070
.659 n/a n/a
.572 n/a n/a
.000 −12.80 (−18.39 to−7.20) .000
.749 5.05 (−0.39 to 10.49) .068
179C. Reilly et al. / Epilepsy & Behavior 52 (2015) 174–179We did not have a control group with which to compare the prevalence
and nature of symptoms of anxiety and depression.
Assessing symptoms of anxiety and depression in children with
epilepsy and intellectual disability presents signiﬁcant assessment
difﬁculties [12]. We were not able to assess self-reported symptoms of
depression and anxiety in children with intellectual disability or parent-
reported symptoms of anxiety in children with an IQ below 35. Despite
difﬁculties in assessment of emotional symptoms in children with intel-
lectual disability, it would have been useful to usemeasures of emotional
functioning suitable for children with this level of cognitive ability.
5. Conclusions
In summary, symptoms of self-reported anxiety and depression ap-
pear to be elevated in community-based children with epilepsy,
highlighting the need for screening in this group. Furthermore, given
that the majority of children who reached diagnostic criteria were
often not identiﬁed, there is a need to investigate possible reasons for
this underrecognition. The fact that parents often report fewer symp-
toms of anxiety and depression highlights the need to garner the
views of the children themselves where possible. Symptoms of anxiety
were more common than symptoms of depression, and there is a need
for further exploration of why this is including an exploration of both
environmental and biological contributors.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yebeh.2015.09.004.
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